The facility is part of the company’s plans to invest $55 billion in U.S. manufacturing, research and development and ...

In March, the company announced a ‌plan to ⁠invest ⁠more than $55 billion through early 2029 to build manufacturing ...

Johnson & Johnson plans to spend more than $1 billion to build a cell therapy manufacturing facility in Montgomery County near Spring House, the New Jersey pharmaceutical and medical supplies giant ...

The cancer-fighting drug manufacturing facility will create 500 new manufacturing jobs and 4,000 construction jobs.

Another of the world’s top pharmaceutical companies is making Pennsylvania a part of major North American expansion plans.

With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson is the latest drugmaker to zero in on expansion ...

Johnson & Johnson (NYSE: JNJ) (the "Company"), healthcare’s leading, most comprehensive innovation powerhouse, today announced a more than $1 billion investment in a next generation cell therapy ...

The pharmaceutical giant said it plans to build a $1B drug manufacturing facility after receiving a $41.5M incentive package ...

Johnson & Johnson will invest more than $1 billion in a next generation cell therapy manufacturing facility in Montgomery County, Pa. The company said the facility will create more than 4,000 ...

Johnson & Johnson said on Wednesday it will invest more than $1 billion to build a new cell therapy facility in Pennsylvania, ...